May 05, 2022 / 08:30PM GMT
Operator
Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics First Quarter 2022 Financial Results Conference Call. (Operator Instructions) Please be advised that today's call is being recorded.
I'd now like to hand the call over to Eric Hyllengren, Vice President of Investor Relations and Finance at Atara Biotherapeutics. Please proceed, sir.
Eric Hyllengren - Atara Biotherapeutics, Inc. - VP of IR & Finance
Thank you, operator. Good afternoon, everyone, and welcome to Atara's First Quarter 2022 Results Conference Call. Earlier today, we issued a press release announcing our first quarter financial results and operational progress. This press release and an updated slide deck are available in the Investors and Media section at atarabio.com. On today's call, members from the Atara executive team will provide an update on our financial results and operational progress and also review our upcoming key milestones and objectives.
Joining me on today's call are Dr. Pascal Touchon, President and Chief Executive
Q1 2022 Atara Biotherapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot